1. CRISPR/Cas9‐mediated mutagenesis to validate the synergy between PARP1 inhibition and chemotherapy in BRCA1‐mutated breast cancer cells. Issue 1 (2nd January 2020) Authors: Mintz, Rachel L.; Lao, Yeh‐Hsing; Chi, Chun‐Wei; He, Siyu; Li, Mingqiang; Quek, Chai Hoon; Shao, Dan; Chen, Boyuan; Han, Jing; Wang, Sihong; Leong, Kam W. Journal: Bioengineering & translational medicine Issue: Volume 5:Issue 1(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗